DSM provides Q1 2023 trading update
02 May 2023
Prioritising profitability over sales volumes has supported our margins, which improved sequentially into the first quarter.”
DSM is a global purpose-led, science-based company founded in 1902 and listed on Euronext Amsterdam. We are a leader in health, nutrition and bioscience which, through our products and solutions, aims to address some of the world’s biggest challenges whilst creating profitable growth in order to simultaneously deliver economic, environmental and societal value for all.
02 May 2023
Prioritising profitability over sales volumes has supported our margins, which improved sequentially into the first quarter.”
28 Apr 2023
Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.
26 Apr 2023
Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.
Geraldine Matchett is Co-Chief Executive Officer, Chief Financial Officer and Member of the Managing Board. She was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2014.
Dimitri de Vreeze is Co-Chief Executive Officer, Chief Operating Officer and Member of the Managing Board. He was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2013.
DSM's Factbook provides investors and analysts with an introduction to the company and our key individual businesses.
DSM's share performance in real time and historically.